A new warning from the US FDA has put the top-selling drugs, gabapentin and pregabalin, sold in India to treat neurological disorders under the blacklist. The U.S. Food and Drug Administration (FDA) has warned serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) who have respiratory risk […]